BXP:NYE-Boston Properties Inc (USD)

COMMON STOCK | REIT - Office |

Last Closing

USD 79.39

Change

+0.36 (+0.46)%

Market Cap

N/A

Volume

1.13M

Analyst Target

USD 105.71
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for REIT - Office

Symbol Name Price(Change) Market Cap
ARE Alexandria Real Estate Equitie..

+0.70 (+0.65%)

USD 18.93B
VNO-PL Vornado Realty Trust

+0.20 (+1.10%)

USD 10.42B
VNO-PM Vornado Realty Trust

+0.07 (+0.39%)

USD 10.42B
VNO Vornado Realty Trust

-0.84 (-1.96%)

USD 8.88B
SLG-PI SL Green Realty Corp

-0.03 (-0.13%)

USD 7.02B
KRC Kilroy Realty Corp

+0.12 (+0.30%)

USD 4.77B
EQC-PD Equity Commonwealth

-0.07 (-0.28%)

USD 3.72B
CDP COPT Defense Properties

-0.66 (-2.08%)

USD 3.69B
DEI Douglas Emmett Inc

-0.07 (-0.39%)

USD 3.62B
OGCP Empire State Realty OP LP

N/A

USD 2.89B

ETFs Containing BXP

GBLD Invesco MSCI Green Buildi.. 4.56 % 0.00 %

-0.14 (0.00%)

USD 8.74M
RSPR Invesco S&P 500® Equal.. 3.57 % 0.00 %

+0.08 (+0.00%)

USD 0.12B
ICAP InfraCap Equity Income Fu.. 3.30 % 0.00 %

-0.03 (0.00%)

USD 0.06B
GEDV:LSE SPDR® S&P® Global Divid.. 2.03 % 0.00 %

+0.01 (+0.00%)

USD 0.02B
ZPRG:F SPDR S&P Global Dividend .. 1.94 % 0.00 %

+0.23 (+0.00%)

USD 1.04B
ZPRG:XETRA SPDR S&P Global Dividend .. 1.94 % 0.00 %

+0.09 (+0.00%)

USD 1.04B
GLDV:SW SPDR® S&P Global Dividen.. 1.94 % 0.00 %

-0.04 (0.00%)

USD 1.29B
ZPD3:XETRA SPDR® S&P® Global Divid.. 1.93 % 0.00 %

+0.08 (+0.00%)

USD 0.02B
RIET Hoya Capital High Dividen.. 1.88 % 0.00 %

-0.04 (0.00%)

USD 0.09B
UBUM:F UBS (Irl) ETF Public Limi.. 1.78 % 0.00 %

-0.01 (0.00%)

USD 0.11B
UBUM:XETRA UBS (Irl) plc – DJ Glob.. 1.78 % 0.00 %

N/A

USD 0.17B
GLDVD:SW UBS (Irl) ETF plc - S&P D.. 1.78 % 0.00 %

N/A

USD 0.11B
SPYD SPDR® Portfolio S&P 500 .. 1.40 % 0.08 %

+0.05 (+0.00%)

USD 6.96B
FLTB Fidelity® Limited Term B.. 0.00 % 0.41 %

+0.04 (+0.00%)

USD 0.18B
PRME Prime Medicine, Inc. Comm.. 0.00 % 0.95 %

-0.36 (0.00%)

N/A
WREI 0.00 % 0.32 %

N/A

N/A
BLES Inspire Global Hope ETF 0.00 % 0.62 %

-0.28 (0.00%)

USD 0.11B
SPDV AAM S&P 500 High Dividend.. 0.00 % 0.29 %

+0.02 (+0.00%)

USD 0.06B
RBND 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Office) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.14% 63% D 61% D-
Dividend Return 5.59% 50% F 78% C+
Total Return 18.73% 63% D 66% D+
Trailing 12 Months  
Capital Gain 39.23% 78% C+ 84% B
Dividend Return 8.59% 64% D 86% B+
Total Return 47.83% 78% C+ 87% B+
Trailing 5 Years  
Capital Gain -42.29% 42% F 11% F
Dividend Return 14.96% 40% F 48% F
Total Return -27.33% 38% F 12% F
Average Annual (5 Year Horizon)  
Capital Gain -4.68% 53% F 14% F
Dividend Return -0.40% 50% F 20% F
Total Return 4.27% 60% D- 78% C+
Risk Return Profile  
Volatility (Standard Deviation) 31.02% 44% F 34% F
Risk Adjusted Return -1.31% 50% F 21% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.